620 related articles for article (PubMed ID: 26764282)
1. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.
Shaverdian N; Tenn S; Veruttipong D; Wang J; Hegde J; Lee C; Cao M; Agazaryan N; Steinberg M; Kupelian P; Lee P
Br J Radiol; 2016; 89(1059):20150963. PubMed ID: 26764282
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
4. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.
Bellec J; Arab-Ceschia F; Castelli J; Lafond C; Chajon E
Radiat Oncol; 2020 Mar; 15(1):54. PubMed ID: 32127010
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
[TBL] [Abstract][Full Text] [Related]
6. Megavoltage conebeam CT cine as final verification of treatment plan in lung stereotactic body radiotherapy.
Kudithipudi V; Gayou O; Colonias A
J Med Imaging Radiat Oncol; 2016 Jun; 60(3):441-5. PubMed ID: 26850083
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations.
Louie AV; Senan S; Dahele M; Slotman BJ; Verbakel WF
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):843-9. PubMed ID: 25585783
[TBL] [Abstract][Full Text] [Related]
8. ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer.
Liang X; Zheng D; Mamalui-Hunter M; Flampouri S; Hoppe BS; Mendenhall N; Li Z
Pract Radiat Oncol; 2019 Jan; 9(1):38-48. PubMed ID: 30138747
[TBL] [Abstract][Full Text] [Related]
9. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
Admiraal MA; Schuring D; Hurkmans CW
Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
[TBL] [Abstract][Full Text] [Related]
10. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
[TBL] [Abstract][Full Text] [Related]
11. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
[TBL] [Abstract][Full Text] [Related]
13. Is internal target volume accurate for dose evaluation in lung cancer stereotactic body radiotherapy?
Peng J; Zhang Z; Wang J; Xie J; Hu W
Oncotarget; 2016 Apr; 7(16):22523-30. PubMed ID: 26968812
[TBL] [Abstract][Full Text] [Related]
14. Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer.
Ge H; Cai J; Kelsey CR; Yin FF
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):438-43. PubMed ID: 22687196
[TBL] [Abstract][Full Text] [Related]
15. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
16. Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study.
de Figueiredo BH; Antoine M; Trouette R; Lagarde P; Petit A; Lamare F; Hatt M; Fernandez P
Radiat Oncol; 2014 Dec; 9():300. PubMed ID: 25534014
[TBL] [Abstract][Full Text] [Related]
17. Mid-ventilation based PTV margins in Stereotactic Body Radiotherapy (SBRT): a clinical evaluation.
Peulen H; Belderbos J; Rossi M; Sonke JJ
Radiother Oncol; 2014 Mar; 110(3):511-6. PubMed ID: 24560765
[TBL] [Abstract][Full Text] [Related]
18. Dynamic simulation of motion effects in IMAT lung SBRT.
Zou W; Yin L; Shen J; Corradetti MN; Kirk M; Munbodh R; Fang P; Jabbour SK; Simone CB; Yue NJ; Rengan R; Teo BK
Radiat Oncol; 2014 Nov; 9():225. PubMed ID: 25365935
[TBL] [Abstract][Full Text] [Related]
19. Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity.
Franks KN; Purdie TG; Dawson LA; Bezjak A; Jaffray DA; Bissonnette JP
Med Dosim; 2010; 35(2):101-7. PubMed ID: 19931021
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer.
Matsugi K; Nakamura M; Miyabe Y; Yamauchi C; Matsuo Y; Mizowaki T; Hiraoka M
Radiol Phys Technol; 2013 Jan; 6(1):233-40. PubMed ID: 23247576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
